Clopidogrel resistance is associated with thromboembolic complications in patients undergoing neurovascular stenting (Q44299095)

1 December 2017

Clopidogrel resistance is associated with thromboembolic complications in patients undergoing neurovascular stenting (English)

1 reference

1 December 2017

0 references

1 reference

1 reference

1

J T Fifi

1 reference

1 December 2017

C Brockington

2

1 reference

1 December 2017

J Narang

3

1 reference

1 December 2017

W Leesch

4

1 reference

1 December 2017

S L Ewing

5

1 reference

1 December 2017

H Bennet

6

1 reference

1 December 2017

A Berenstein

7

1 reference

1 December 2017

J Chong

8

1 reference

1 December 2017

language of work or name

1 reference

29 November 2012

1 reference

American Journal of Neuroradiology

1 December 2017

1 reference

1 December 2017

34

1 reference

1 December 2017

4

1 reference

1 December 2017

716-720

1 reference

Stenting versus aggressive medical therapy for intracranial arterial stenosis

1 December 2017

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3405

Antiplatelet resistance and thromboembolic complications in neurointerventional procedures.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3405

A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3405

Anti-thrombotic medications for the neurointerventionist: aspirin and clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3405

Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3405

Individual variations of platelet inhibition after loading doses of clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3405

Onset and offset of platelet inhibition after high-dose clopidogrel loading and standard daily therapy measured by a point-of-care assay in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3405

Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3405

Prevalence of aspirin and clopidogrel resistance among patients with and without drug-eluting stent thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3405

Dual antiplatelet therapy monitoring for neurointerventional procedures using a point-of-care platelet function test: a single-center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3405

Monitoring of clopidogrel-related platelet inhibition: correlation of nonresponse with clinical outcome in supra-aortic stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3405

Prevalence and risk factors for aspirin and clopidogrel resistance in cerebrovascular stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3405

Body weight: a risk factor for subtherapeutic antithrombotic therapy in neurovascular stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3405

Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3405

Justification of 150 mg clopidogrel in patients with high on-clopidogrel platelet reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3405

The clopidogrel resistance can be attenuated with triple antiplatelet therapy in patients undergoing drug-eluting stents implantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3405

Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3405

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3405

Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3405

Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3405

Impact of cytochrome P450 2C19 loss-of-function polymorphism and of major demographic characteristics on residual platelet function after loading and maintenance treatment with clopidogrel in patients undergoing elective coronary stent placement

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3405

Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3405

High on-treatment platelet reactivity to both aspirin and clopidogrel is associated with the highest risk of adverse events following percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3405

Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3405

Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3405

Prasugrel versus clopidogrel in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3405

21 January 2018

Identifiers

DOI

10.3174/AJNR.A3405

1 reference

1 December 2017

1 reference